AI assistant
HERBALIFE LTD. — Director's Dealing 2018
Mar 8, 2018
32337_dirs_2018-03-08_47ac3eb5-047d-4bbc-b0e5-3c1027f21b6b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HERBALIFE LTD. (HLF)
CIK: 0001180262
Period of Report: 2018-03-06
Reporting Person: Chiu Shin-Shing Bosco (Principal Accounting Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-03-06 | Common Stock | M | 15396 | $59.98 | Acquired | 17278 | Direct |
| 2018-03-06 | Common Stock | D | 9538 | $96.84 | Disposed | 7740 | Direct |
| 2018-03-06 | Common Stock | F | 2908 | $96.84 | Disposed | 4832 | Direct |
| 2018-03-06 | Common Stock | M | 18760 | $30.44 | Acquired | 23592 | Direct |
| 2018-03-06 | Common Stock | D | 5899 | $96.84 | Disposed | 17693 | Direct |
| 2018-03-06 | Common Stock | F | 6379 | $96.84 | Disposed | 11314 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-03-06 | Stock Appreciation Rights | $59.98 | M | 15396 | Disposed | 2024-04-30 | Common Stock (15396) | Direct |
| 2018-03-06 | Stock Appreciation Rights | $30.44 | M | 18760 | Disposed | 2025-03-02 | Common Stock (18760) | Direct |
Footnotes
F1: The reporting person received 2,950 shares of common stock upon the net exercise of 15,396 stock appreciation rights ("SARS"). The reporting person forfeited 9,538 shares of common stock underlying the SARS in payment of the exercise price and 2,908 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on March 6, 2018 of $96.84.
F2: The reporting person received 6,482 shares of common stock upon the net exercise of 18,760 SARs. The reporting person forfeited 5,899 shares of common stock underlying the SARS in payment of the exercise price and 6,379 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on March 6, 2018 of $96.84.